Following one of the most dramatic weeks of his presidency, Trump’s job approval rating has dropped to its lowest point, now at 39% approval.
In the latest Reuters/Ipsos Core Political, concerns over healthcare remain high.
In the latest Reuters/Ipsos Core Political, concern over healthcare grows.
On June 2, join Ipsos Healthcare’s Marco Dibonaventura who will be presenting at this year’s conference dedicated to the brightest minds of oncology.
Ipsos Healthcare has extended its syndicated Psoriasis and IBD Therapy Monitors into China. It will also re-launch the Lupus Therapy Monitor in China due to increased client demand
Over half of Americans (55%) still believe the country is on the wrong track, with less than a third believing we are heading in the right direction (29%).
On May 20, please join the Ipsos Healthcare team who’ll be presenting data on key topics in NASH, Oncology, Diabetes and Obesity, as well as exhibiting at the 22nd International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting.
In the latest Reuters/Ipsos Core Political, many are confident in President Trump’s dealing with ISIS/ISIL and his handling of terrorism.
The Future Cities Dialogue engaged urban citizens in possible future urban scenarios. Citizen feedback on their preferences and priorities for future urban living is feeding into Innovate UK’s broader work on future urban systems integration and understanding and identifying the market opportunities this generates.
As we enter the final quarter of President Trump’s first 100 days, our polls show the country is no more unified or optimistic than when he took office.